期刊文献+

甘精胰岛素对吞咽困难2型糖尿病患者的应用研究

下载PDF
导出
摘要 目的观察甘精胰岛素在吞咽困难2型糖尿病患者的降糖疗效和安全性。方法选择2型糖尿病患者伴吞咽困难需要鼻饲者77例,随机分组为甘精胰岛素输注观察组39例,胰岛素泵持续皮下输注对照组38例。比较两组患者降糖效果、血糖控制时间、低血糖发生率等方面的差异。结果两组患者治疗后血糖值均显著下降,与治疗前比较有显著性差异(P<0.05);观察组血糖控制时间和低血糖发生率有降低趋势,在血糖控制时间上两组比较有显著性差异(P<0.05)、但在血糖、低血糖发生率方面两组比较无统计学差异(P>0.05)。结论采用甘精胰岛素应用在2型糖尿病伴吞咽困难患者可以快速、有效、安全控制血糖。
出处 《中国实用医药》 2010年第21期136-137,共2页 China Practical Medicine
  • 相关文献

参考文献2

  • 1程伟,严钟穗.长效胰岛素类似物的临床研究进展[J].国外医学(内分泌学分册),2003,23(4):237-239. 被引量:28
  • 2HamannA,Matthaei S,Rosak C,et al.Arandomized clinical trial comparing breakfast,dinner,or bedtime administration of insulin glargine in patients with type 1 diabetes.Diabetes Care,2003,26:1738-1744.

二级参考文献15

  • 1Ebeling P, Jansson P A, Smith U, et al. Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin[J]. Diabetes Care, 1997,20 : 1287-1289.
  • 2Rosskamp R H, Park G. Long-acting insulin analogs[J].Diabetes Care,1999, 22(Suppl 2) :B109-B113.
  • 3Vajo Z, Fawcett J, Duckworth W C. Recombinant DNA technology in the treatment of diabetes [ J]. Endocr Rev, 2001,22:706-717.
  • 4McKeage K, Goa K L. Insulin Glargine [ J ]. Drugs, 2001,61 :1599-1624.
  • 5Heinemann L, Linkeschova R, Rave K. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo[J]. Diabetes Care, 2000,23 : 644-649.
  • 6Talaulicar M, Willms B, Rosskamp R. HOE901, ein neues insulin analog zur substitution des basalen insulin-bedarfs bei type 1 diabetes[ J ]. Diabetes Stoffwechsel, 1996,5 : 3-6.
  • 7Ratner R E, Hirsch I B, Neifing J L. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes[J]. Diabetes Care ,2000,23 : 639-643.
  • 8Yki-Jarvinen H, Dressler A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes [ J ] .Diabetes Care,2000,23 : 1130-1136.
  • 9Hershon K, Blevins T, Donley D, et al. Lower fasting blood glucose(FBG) and less symptomatic hypoglycemia with QD insulin glargine(Lautus) compare to bid NPH insulin in subjects with type 1 diabetes[J]. Diabetes,2001,50( Suppl 2) :116-117.
  • 10Fonseca V, Bell D, Mecca T. Less symptomatic hypoglycemia with bedtime insulin glargine compared to bedtime NPH insulin in patients with type 2 diabetes [ J] . Diabetes, 2001,50(Suppl 2) : 112-113.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部